Get started
Author

muhammed Fatih Sağıroğlu

Observed names: Muhammed Fatih SAĞIROĞLU, Muhammed Fatih Sagiroglu, Muhammed Fatih Sagıroglu, Muhammed Fatih Sağıroğlu
ORCID: 0000-0002-3253-6112
Observed ORCID: 0000-0002-3253-6112
OpenAlex ID: A5034348467
Control of Refractory Hypercalcemia with Denosumab in a Case of Metastatic Parathyroid Carcinoma
2020 · Murat Çalapkulu, Ozen Oz Gul, et al. · Journal of College of Physicians And Surgeons Pakistan · 10
PDF
Co-existence of Papillary and Medullary Thyroid Carcinoma: Reports of Three Cases
2022 · Murat Calapkulu, Ozen Oz Gul, et al. · Journal of College of Physicians And Surgeons Pakistan · 7
PDF
Gastroenteroloji Kliniğine Başvuran Akut Üst Gastrointestinal Sistem Kanamalı Hastaların Retrospektif Değerlendirilmesi
2020 · Muhammed Fatih SAĞIROĞLU, Murat ÇALAPKULU, et al. · Uludağ Üniversitesi Tıp Fakültesi Dergisi · 5
PDF
Survival Outcomes in Metastatic Germ Cell Tumors: A Multicenter Study from Turkey
2025 · Gul Sema Yildiran Keskin, Ozge Yetginoglu, et al. · Medicina · 3
PDF
Comparison of Frontline FOLFIRINOX with Fluorouracil-Based and Gemcitabine-Based Chemotherapies in Metastatic Ampullary Adenocarcinoma: A Multicenter Study by the Turkish Oncology Group (TOG)
2025 · Ali Kalem, Tulay Kus, et al. · Journal of Clinical Medicine · 1
PDF
Pain Severity, Social Functioning and Analgesic Patterns in Cancer Outpatients with Pain: A Cross-Sectional Study of 272 Patients in Türkiye
2026 · Muhammed Fatih Sagiroglu, Serife Sivridemir, et al. · Current Oncology
Preoperative Lactate Dehydrogenase-to-Albumin Ratio as a Tumor–Host Biomarker of Early Recurrence and Survival in Resected Pulmonary Neuroendocrine Carcinomas: A Multicenter Observational Cohort Study
2026 · Hacer Boztepe Yesilcay, Asim Armagan Aydin, et al. · Medicina
Tyrosine Kinase Inhibitor Therapy in Metastatic Medullary Thyroid Carcinoma: Real-World Data from Turkish Oncology Group
2026 · Sedat Yıldız, Hacer Demir, et al. · Journal of Clinical Medicine
PDF
FOLFIRINOX: The Best Adjuvant Treatment for Ampullary Adenocarcinoma? A Multicenter Study by the Turkish Oncology Group (TOG)
2025 · Ali Kalem, Tulay Kus, et al. · Cancers
PDF
FOLFIRINOX: The best adjuvant treatment for ampullary adenocarcinoma?
2025 · Ali̇ Kalem, Tulay Kus, et al. · Journal of Clinical Oncology
Comparison of frontline FOLFIRINOX with fluorouracil-based and gemcitabine-basedchemotherapies in metastatic ampullary adenocarcinoma: A multicenter cohort study.
2025 · Ali̇ Kalem, Tulay Kus, et al. · Journal of Clinical Oncology
PDF
Works count: 11
Citation count: 26
H-index: 3
I10-index: 1
Year
Topic
Type